Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease

Circulation

Volumn 96, Issue 8, 1997, Pages 2578-2585

  Lüscher, Michael Stausboøll ^a   Thygesen, Kristian ^a   Ravkilde, Jan ^a   Heickendorff, Lene ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angina troponin; Myocardial infarction; Prognosis

Indexed keywords

INOGATRAN; THROMBIN INHIBITOR; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0342378053     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2578     Document Type: Article

References (29)

1. Fragmin During Instability in Coronary Artery Disease (FRISC) Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 1996;347:561-568.
2. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827-830.
3. Ohman ME, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Leiman NS, Harrell FE, Califf RM, Topol EJ, for the GUSTO-IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
4. Ravkilde J, Nissen H, Hørder M, Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction: analysis of 28 months follow-up in 196 patients. J Am Coll Cardiol. 1995;25:574-581.
5. Collinson PO, Moseley D, Stubbs PJ, Carter GD. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Ann Clin Biochem. 1993;30:11-16.
6. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 1996;93:1651-1657.
7. Antman EM, Milenko J, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
8. Wu AHB, Feng YJ, Contois JH, Azar R, Waters D. Prognostic value of cardiac troponin I in patients with chest pain. Clin Chem. 1996;42:651-652. Letter.
9. Madsen JK, Thomsen BL, Mellemgaard K, Hansen JF. Independent prognostic risk factors for patients referred because of suspected acute myocardial infarction without confirmed diagnosis: prognosis after discharge in relation to medical history and non-invasive investigations. Eur Heart J. 1988;9:610-618.
10. Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol. 1992;19: 1659-1663.
11. Rude RE, Poole WK, Muller JE. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3697 patients. Am J Cardiol. 1983;52:936-942.
12. Wu AHB, Lane PL. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem. 1995;41:1228-1233.
13. Mair J, Artner-Dworzak E, Lechleiter P, Smidt J, Wagner I, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of acute myocardial infarction. Clin Chem. 1991;37:845-852.
14. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, Noe A, Matern G, Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902-912.
15. Gerhardt W, Katus HA, Ravkilde J, Hamm C, Jørgensen PJ, Peheim E, Ljungdahl L, Löfdahl P. S-Troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of s-creatine kinase MB. Clin Chem. 1991;37:1405-1411.
16. Gerhardt W, Ljungdahl L, Herbert A, Troponin T and CK-MB (mass) in early diagnosis of ischemic myocardial injury: the Helsingborg study, 1992. Clin Biochem. 1993;26:231-240.
17. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, Essig U, Geuss U. Development and in vitro characterisation of a new immunoassay of cardiac troponin T. Clin Chem. 1992;38:286-393.
18. Müller-Bardorff M, Hallermayer K, Schröder A, Ebert C, Borgya A, Gerhardt W, Remppis A, Zehelein J, Katus HA. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 1997;43:458-466.
19. Lindahl B, Venge P, Wallentin L, for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol. 1997;29:43-48.
20. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem. 1993;39: 972-979.
21. Cummings B, Auckland ML, Cummings P. Cardio-specific troponin-I radio-immunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113:1333-1344.
22. Bodor GS, Porter S, Landt Y, Landerson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992;38:2203-2214.
23. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 1994;40: 1291-1295.
24. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, Rusticali F, Jaffe AS. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 1997;95:2053-2059.
25. Thrombin Inhibition in Myocardial Ischaemia (TRIM) study group. A low-molecular-weight, selective thrombin inhibitor, Inogatran, versus heparin in unstable coronary artery disease in 1209 patients: a double blind, randomised, dose-finding study. Eur Heart J. 1997; 18:1416-1425.
26. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation. 1994;89:1545-1556.
27. Wu AHB, Abbas SA, Green S, Pearsall L, Dhakam S, Azar R, Onoroski M, Senaie A, McKay RG, Waters D. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 1995; 25:574-581.
28. Hamm CW, Ravkilde J, Gerhardt W, Jørgensen P, Peheim E, Ljungdahl L, Goldmann B, Katus HA. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327: 146-150.
29. Ravkilde J, Hørder M, Gerhardt W, Ljungdahl L, Pettersson T, Tryding N, Møller BH, Hamfelt A, Graven T, Asberg A, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest. 1993;53:677-685.